Site TW88602

Taipei 114

1 studies enrolling now · 5 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Solid Tumors, Allogeneic, Hematopoietic Cell Transplant (HCT), Cytomegalovirus (CMV)-Positive Recipients, Leukemia, Acute Myeloid (AML), Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer, Prostate Cancer

Studies at this site

• A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer — Recruiting now
• A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation — Completed
• A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) — Completed
• A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors — Completed
• A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT) — Completed